IL2 and hepatocellular carcinoma: The addition of IL-2 stimulated primary NK cells and sNK cells derived supernatants was able to consistently upregulate MHC-class I and CD54 in poorly-differentiated HCC (SNU-423), confirming decreased stem-like profile and likely increased susceptibility to TCR-based recognition (Figure 3A).